New Zealand Autism Spectrum Disorder Guideline - Ministry of Health

References
274. Green CJ, Bassett K, Kazanjian A. Critical
appraisal of submitted cost-benefit models
of ‘Lovaas’ early intensive behavioural
intervention for autism. Vancouver: University
of British Columbia: Centre of Health Services
and Policy Research, 2000:1-19.
275. Bassett K, Green CJ, Kazanjian A. Autism
and Lovaas treatment: A systematic review of
effectiveness evidence. Vancouver: University
of British Columbia: Centre for Health Services
and Policy, 2000:i-ix, 1-57.
276. Bodfish JW. Treating the core features of
autism: are we there yet? Mental Retardation &
Developmental Disabilities Research Reviews 2004;
10(4):318-26.
277. Howlin P. The effectiveness of interventions
for children with autism. Journal of Neural
Transmission 2005; Supplementum.(69):101-19.
278. Freeman B. Guidelines for evaluating
intervention programs for children with
autism. Journal of Autism and Developmental
Disorders 1997; 27(6):641-651.
279. Grice BL, Judging the effectiveness of a
treatment: a list of criteria for parents to use to
evaluate a child’s programme. Conference of
the Autistic Association of New Zealand; 1997;
Wellington.
280. Edelson SM. How to determine if a treatment
really helped. http://www.autism.org/
determine.html. 20 September 2004.
281. Simpson RL. Evidence-based practices and
students with autism spectrum disorders.
Focus on Autism and Other Developmental
Disabilities 2005; 20(3):140-149.
282. McVilly K. Positive behaviour support for people
with intellectual disability. Sydney, 2002.
283. Carr JE, Sidener TM. On the relation between
applied behavior analysis and positive
behavioral support. The Behavior Analyst 2002;
25:245-253.
284. Autism Special Interest Group. Revised
Guidelines for Consumers of Applied
Behavior Analysis Services to Individuals with
Autism and Related Disorders. http://www.
abainternational.org/sub/membersvcs/sig/
contactinfo/Autism.asp. 20 January 2005.
285. Mandre E, Individualized educational
treatment for adult psychiatric patients with
autism spectrum disorders. 12th Annual
International Durham Conference on Autism;
2002 10-12 April Durham. Certec, Department
of Design Sciences, Lund University.
286. Mandre E. From medication to education:
people with autism in adult psychiatry.
Lund University, 2002.
287. Hare DJ. Developing cognitive behavioural
work with people with ASD. Good Autism
Practice 2004; 5(1):18-22.
288. Connolly SD, Bernstein GA, Work Group
on Quality I. Practice parameter for the
assessment and treatment of children and
adolescents with anxiety disorders. Journal
of the American Academy of Child & Adolescent
Psychiatry 2007; 46(2):267-83.
289. Attwood T. Cognitive Behaviour Therapy.
In: Holliday Willey L, editor. Asperger
Syndrome in Adolescence: Living with the Ups, the
Downs and Things in Between. London: Jessica
Kingsley Publishers Ltd, 2003.
290. Reaven J, Hepburn J. Cognitive-behavioral
treatment of obsessive-compulsive disorder in
a child with Asperger syndrome. Autism 2003;
7(2):145-164.
291. Attwood T. Cognitive behaviour therapy for
children and adults with Asperger syndrome.
Behaviour Change 2004; 21(3):147-161.
292. Chui J, Tordoff J, Kennedy J, et al. Trends
in accessibility to medicines for children in
New Zealand: 1998-2002. British Journal of
Clinical Pharmacology 2004; 57(3):322-7.
293. Santosh PJ, Baird G, Pityaratstian N, et
al. Impact of comorbid autism spectrum
disorders on stimulant response in children
with attention deficit hyperactivity disorder:
a retrospective and prospective effectiveness
study. Child: Care, Health & Development 2006;
32:575-583.
294. Gringras P. Practical paediatric
psychopharmacological prescribing in autism:
the potential and the pitfalls. Autism 2000;
4:229-47.
295. McClellan JM, Werry JS. Evidence-based
treatments in child and adolescent psychiatry:
an inventory. Journal of the American Academy of
Child and Adolescent Psychiatry 2003; 42:1388-
1400.
296. Santosh PJ, Baird G. Psychopharmacotherapy
in children and adults with intellectual
disability. Lancet 1999; 354:233-42.
297. Hollander E, Phillips A, Chaplin W, et al.
A placebo-controlled crossover trial of
liquid fluoxetine on repetitive behaviors
in childhood and adolescent autism.
Neuropsychopharmacology 2005; 30(3):582-9.
References
New Zealand Autism Spectrum Disorder Guideline 233